Cargando…

Vaccine Escape Recombinants Emerge after Pneumococcal Vaccination in the United States

The heptavalent pneumococcal conjugate vaccine (PCV7) was introduced in the United States (US) in 2000 and has significantly reduced invasive pneumococcal disease; however, the incidence of nonvaccine serotype invasive disease, particularly due to serotype 19A, has increased. The serotype 19A increa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brueggemann, Angela B, Pai, Rekha, Crook, Derrick W, Beall, Bernard
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077903/ https://www.ncbi.nlm.nih.gov/pubmed/18020702 http://dx.doi.org/10.1371/journal.ppat.0030168

Ejemplares similares

Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event
por: Golubchik, Tanya, et al.
Publicado: (2012)

180. Impact of Pneumococcal Conjugative Vaccine on Antibiotic Resistant Invasive Pneumococcal Disease in the United States
por: Bajema, Kristina, et al.
Publicado: (2020)

647 Impact of 13-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in the United States
por: Kim, Lindsay, et al.
Publicado: (2014)

Evidence for Soft Selective Sweeps in the Evolution of Pneumococcal Multidrug Resistance and Vaccine Escape
por: Croucher, Nicholas J., et al.
Publicado: (2014)

1470. Epidemiology of Invasive Pneumococcal Disease (IPD) Following 18 years of Pneumococcal Conjugate Vaccine (PCV) Use in the United States
por: Pilishvili, Tamara, et al.
Publicado: (2020)

An Assessment of the Screening Method to Evaluate Vaccine Effectiveness: The Case of 7-Valent Pneumococcal Conjugate Vaccine in the United States
por: Cohen, Adam L., et al.
Publicado: (2012)

Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
por: Chen, Jieling, et al.
Publicado: (2014)

1097 Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
por: Yang, H. Keri, et al.
Publicado: (2014)

Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011
por: Richter, Sandra S., et al.
Publicado: (2013)

1373. Vaccine Effectiveness and Pneumococcal Serotypes in Pediatric Otitis Media in the Era of Routine 13-valent Pneumococcal Vaccination in the United States
por: Hulten, Kristina G, et al.
Publicado: (2020)

Population Genetic Structure of Streptococcus pneumoniae in Kilifi, Kenya, Prior to the Introduction of Pneumococcal Conjugate Vaccine
por: Brueggemann, Angela B., et al.
Publicado: (2013)

1094 Pneumococcal Vaccination Coverage In The Elderly In The United States: Missed Opportunities Continue
por: Yang, H. Keri, et al.
Publicado: (2014)

06. United States Healthcare Provider Preferences for Adult Pneumococcal Vaccine Recommendations
por: Vietri, Jeffrey, et al.
Publicado: (2021)

1740. Healthcare Providers’ Preferences for Pediatric Pneumococcal Vaccination Recommendations in the United States
por: Vietri, Jeffrey T, et al.
Publicado: (2023)

Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland
por: Quirk, Sigríður J., et al.
Publicado: (2019)

An evaluation of emerging vaccines for childhood pneumococcal pneumonia
por: Webster, Julia, et al.
Publicado: (2011)

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination
por: van den Biggelaar, Anita H. J., et al.
Publicado: (2017)

Preferences for Adult Pneumococcal Vaccine Recommendations Among United States Health Care Providers
por: Sacco, Patricia, et al.
Publicado: (2019)

Variation of Pneumococcal Pilus-1 Expression Results in Vaccine Escape during Experimental Otitis Media [EOM]
por: Figueira, Marisol, et al.
Publicado: (2014)

Variable recombination dynamics during the emergence, transmission and ‘disarming’ of a multidrug-resistant pneumococcal clone
por: Croucher, Nicholas J, et al.
Publicado: (2014)

1436. Risk Factors for Invasive Pneumococcal Disease in Adults ≥65 Years Old Following Pneumococcal Conjugate Vaccine Recommendation
por: Almendares, Olivia M, et al.
Publicado: (2018)

Emerging vaccine strategies against the incessant pneumococcal disease
por: Duke, Jeremy A., et al.
Publicado: (2023)

Changes in the Pneumococcal Vaccine Serotypes in Adult Noninvasive Pneumonia after the Introduction of Pneumococcal Conjugate Vaccination for Children
por: Takeda, Hiroaki, et al.
Publicado: (2019)

Pneumococcal Capsular Switching: A Historical Perspective
por: Wyres, Kelly L., et al.
Publicado: (2013)

Evaluating immune responses to pneumococcal vaccines
por: Thong, Bernard Yu-Hor, et al.
Publicado: (2023)

Nasopharyngeal Carriage and Transmission of Streptococcus pneumoniae in American Indian Households after a Decade of Pneumococcal Conjugate Vaccine Use
por: Mosser, Jonathan F., et al.
Publicado: (2014)

State of the Globe: Effect of Pneumococcal Conjugate Vaccines on Nonvaccine-type Invasive Pneumococcal Disease
por: Raina, Sunil Kumar
Publicado: (2019)

Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States
por: McLaughlin, John M., et al.
Publicado: (2019)

Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States
por: Senders, Shelly, et al.
Publicado: (2021)

Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.
por: Pilishvili, Tamara, et al.
Publicado: (2017)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
por: Asai, Nobuhiro, et al.
Publicado: (2021)

Global Control of Pneumococcal Infections by Pneumococcal Vaccines
por: Oishi, Kazunori, et al.
Publicado: (2014)

Pneumococcal disease and use of pneumococcal vaccines in Taiwan
por: Wei, Sung-Hsi, et al.
Publicado: (2015)

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Generalized granuloma annulare after pneumococcal vaccination()()
por: García-Gil, Miguel Fernando, et al.
Publicado: (2021)

Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
por: Morais, Victor, et al.
Publicado: (2022)

151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries ≥65 Years Old
por: Pilishvili, Tamara, et al.
Publicado: (2018)

Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Kobayashi, Miwako, et al.
Publicado: (2022)

Evolution of Pneumococcal Vaccine Recommendations and Criteria for Decision Making in 5 Western European Countries and the United States
por: Noharet-Koenig, Roxane, et al.
Publicado: (2023)

ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children ― United States, 2023
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vg4eplesdtbv5366p07h66s783